A 30mg vial of Nicotinamide Adenine Dinucleotide (NAD+) provides a precise, high-purity mass engineered for specialized in vitro assays, cell culture supplementation, and baseline enzymatic pathway experiments. Designed for research facilities requiring moderate aliquot volumes without high risk of waste from repeated thaw cycles, this standardized quantity ensures optimal reagent stability. Below is a comprehensive breakdown of technical specifications, volumetric reconstitution calculations, certificate of analysis (COA) interpretation, and lab handling protocols.
A 30mg vial of Nicotinamide Adenine Dinucleotide (NAD+) provides a precise, high-purity mass engineered for specialized in vitro assays, cell culture supplementation, and baseline enzymatic pathway experiments. Designed for research facilities requiring moderate aliquot volumes without high risk of waste from repeated thaw cycles, this standardized quantity ensures optimal reagent stability. Below is a comprehensive breakdown of technical specifications, volumetric reconstitution calculations, certificate of analysis (COA) interpretation, and lab handling protocols.
In laboratory settings, the 30mg NAD+ vial configuration represents a specialized mass tailored for targeted preclinical experiments. Nicotinamide Adenine Dinucleotide (oxidized form, NAD+) is a critical coenzyme involved in cellular redox reactions, energy transduction, and signal transduction cascades. Laboratories typically select a 30mg unit size when performing medium-throughput microplate assays, enzyme kinetics studies (such as sirtuin or PARP activation assays), or short-term cell culture studies where reconstituted reagent volume must be consumed within a narrow timeframe to prevent hydrolytic degradation.
When inspecting a standard 30mg vial, researchers will observe a dense, lyophilized cake or off-white powder sealed under inert atmospheric conditions (typically nitrogen flushed) in an amber or clear USP Type I borosilicate glass vial. This packaging architecture minimizes exposure to atmospheric moisture and photo-oxidation. While PX1 Research supplies a broad range of high-purity NAD+ research vials across standardized unit sizes—including 100mg, 500mg, and larger bulk quantities—the 30mg format serves as an ideal intermediate unit for exploratory benchtop workflows where preserving reagent freshness is paramount.
Nicotinamide Adenine Dinucleotide (CAS Number: 53-84-9) possesses a molecular weight of approximately 663.43 g/mol. Structure-wise, it consists of two nucleotide units joined through their phosphate groups: one nucleotide containing an adenine nucleobase and the other containing nicotinamide. Preclinical studies suggest that the ratio of NAD+ to its reduced counterpart (NADH) dictates the cellular redox state, directly modulating electron transport chain flux within the inner mitochondrial membrane.
Beyond its classic role as an electron acceptor in glycolysis and the tricarboxylic acid (TCA) cycle, in vitro data indicate that NAD+ serves as an essential obligate substrate for non-redox signaling enzymes. These include class III histone deacetylases (sirtuins, SIRT1–SIRT7), poly(ADP-ribose) polymerases (PARP1–PARP3), and cyclic ADP-ribose synthases (CD38, CD157). Because these enzymes consume NAD+ by cleaving its glycosidic bond to release nicotinamide and ADP-ribose, maintaining precise molar concentrations during in vitro culture or enzymatic assays is critical for producing reproducible experimental outcomes. Researchers exploring broader cellular energy pathways frequently evaluate NAD+ alongside other metabolic modulators available across our catalog of all research peptides and small molecules.
Achieving exact working concentrations requires careful volumetric calculation when reconstituting a 30mg NAD+ cake. The choice of solvent volume depends entirely on the target concentration needed for stock solutions or final assay dilutions. Common laboratory diluents include sterile bacteriostatic water (0.9% benzyl alcohol), sterile phosphate-buffered saline (PBS, pH 7.4), or sterile water for injection (WFI). Below are the standard volumetric dilutions for a 30mg vial:
1.0 mL Diluent Addition: Adding 1.0 mL of solvent yields a stock concentration of 30.0 mg/mL (30.0 µg/µL). In molar terms, using a molecular weight of 663.43 g/mol, a 30 mg/mL solution equals approximately 45.22 mM (millimolar).
2.0 mL Diluent Addition: Adding 2.0 mL of solvent yields a stock concentration of 15.0 mg/mL (15.0 µg/µL), corresponding to a molar concentration of approximately 22.61 mM.
3.0 mL Diluent Addition: Adding 3.0 mL of solvent yields a stock concentration of 10.0 mg/mL (10.0 µg/µL), corresponding to a molar concentration of approximately 15.07 mM.
To quickly verify custom volumes or calculate micro-molar working solutions for microplate wells, lab personnel are encouraged to utilize the PX1 Reconstitution Calculator. Always ensure the lyophilized cake is fully dissolved via gentle swirlling at room temperature rather than high-shear vortexing to prevent air entrapment and bubble formation.
Reconstituted NAD+ in aqueous solution is susceptible to gradual hydrolysis over time, particularly when subjected to ambient temperatures or repeated freeze-thaw cycles. Hydrolysis breaks the pyrophosphate linkage or the nicotinamide-ribose bond, generating nicotinamide and free ADP-ribose, which can inhibit target enzymes or alter baseline assay controls.
To maximize reagent integrity, establish a strict aliquoting protocol immediately following reconstitution. Reconstitute the 30mg vial with the desired diluent under sterile laminar flow hood conditions. Working rapidly, partition the master stock solution into single-use microcentrifuge tubes (e.g., 50 µL to 200 µL volumes depending on daily assay consumption). Snap-freeze these aliquots in liquid nitrogen or an ethanol-dry ice bath, and store them at -80°C (or -20°C for short-term use up to 30 days). Avoid standard frost-free freezers, as their temperature cycling accelerates biochemical degradation. Once an aliquot is thawed for an experiment, discard any unused portion at the end of the procedure.
Maintaining rigorous experimental reproducibility demands verifiable purity and exact mass verification. Every lot of NAD+ processed through PX1 Research undergoes strict third-party analytical testing in ISO 17025 accredited facilities. High-Performance Liquid Chromatography (HPLC) is employed to confirm chemical purity, ensuring that the compound meets or exceeds a baseline purity threshold of 98.0%. Liquid Chromatography-Mass Spectrometry (LC-MS) verifies the exact molecular weight and structural identity, confirming the absence of unreacted precursors or degraded sub-products.
In addition to purity and mass identity, quantitative endotoxin testing is conducted using Limulus Amebocyte Lysate (LAL) assays to ensure endotoxin levels remain below stringent research limits (<0.01 EU/mg). Researchers can verify these analytical parameters prior to unboxing by navigating to the dedicated PX1 Certificate of Analysis (COA) portal, where lot-matched documentation is published for immediate verification.
Determining whether a 30mg vial size or a larger mass format is ideal depends primarily on assay throughput, duration, and storage constraints. A 30mg vial is optimal for small-scale pilot studies, high-concentration single-run microplate assays, or laboratories operating without long-term -80°C storage infrastructure. Conversely, laboratories executing high-throughput screening campaigns or continuous cell culture models typically opt for larger mass sizes, such as 100mg, 500mg, or 1000mg vials, to reduce lot-to-lot variance across long-term protocols.
When mapping out comprehensive metabolic or cellular energy protocols, researchers frequently compare or combine NAD+ with other compounds targeting mitochondrial bioenergetics and metabolic pathways. For example, mitochondrial research clusters often evaluate NAD+ alongside MOTS-c, a mitochondrial-derived peptide involved in metabolic homeostasis, 5-Amino-1MQ, a selective NNMT inhibitor studied for cellular energy regulation, and SS-31, a cardiolipin-targeted mitochondrial peptide. Investigating these distinct mechanisms provides a multi-faceted approach to cellular bioenergetics in preclinical models. For detailed literature reviews on these targets, visit our central research library.
NAD+ is highly soluble in aqueous media, dissolving readily at concentrations exceeding 50 mg/mL in water or physiological buffers. However, researchers must pay close attention to buffer pH and temperature during preparation. In basic environments (pH > 8.5), the nicotinamide ring of NAD+ can undergo alkaline cleavage, whereas extremely acidic conditions (pH < 3.0) can promote cleavage of the purine nucleoside bond.
For optimal stability during extended enzymatic assays, maintain reconstituted NAD+ solutions within a pH range of 6.0 to 7.5. If supplementing cell culture media, filter-sterilize the reconstituted solution through a 0.22-micron polyethersulfone (PES) membrane before introduction to sterile culture vessels. Avoid cellulose acetate filters, which may bind small organic cofactors non-specifically.
PX1 Research operates strictly as a USA-based supplier dedicated to serving academic, biotechnology, and institutional research laboratories. All compounds are manufactured under strict quality standards within GMP-compliant facilities. Reagent integrity is preserved through direct inventory control and expedited logistics dispatching directly from primary facilities in California and Arizona.
Orders placed Monday through Friday before cut-off times ship same-day to minimize transit duration. For institutions managing high-volume research pipelines, specialized procurement options and bulk volume tiering are available through our wholesale lab accounts program. Every unit supplied is strictly for in vitro, laboratory, and preclinical research applications.
What physical state should I expect for a 30mg NAD+ vial upon arrival?
The 30mg NAD+ research vial arrives as a dense, lyophilized (freeze-dried) cake or off-white powder sealed under inert gas inside a glass vial to prevent moisture ingress and ambient degradation.
How do I calculate a 10 mM working concentration from a 30mg NAD+ vial?
To prepare a 10 mM stock solution from 30mg of NAD+ (molecular weight ~663.43 g/mol), dissolve the entire 30mg cake in 4.52 mL of sterile diluent. You can verify custom stock concentrations using the PX1 Reconstitution Calculator.
Can reconstituted NAD+ be stored at room temperature?
No. Reconstituted NAD+ in aqueous solution is prone to hydrolysis at room temperature. Stock solutions should be aliquoted and frozen immediately at -20°C or -80°C for maximum stability.
What analytical parameters are documented on the lot-matched COA?
Each lot-matched COA provides raw analytical data including HPLC purity percentages (≥98%), mass spectrometry identity confirmation, and LAL chromogenic endotoxin assay results (<0.01 EU/mg).
What is the primary difference between a 30mg vial and larger 100mg or 500mg fill sizes?
The biochemical compound is identical. The 30mg vial is designed for low-to-medium volume assays to reduce freeze-thaw cycles, whereas 100mg or 500mg sizes are intended for high-throughput screening or large cell culture protocols.
Is NAD+ soluble in standard cell culture media and PBS?
Yes, NAD+ exhibits high aqueous solubility in standard buffers like phosphate-buffered saline (PBS) and neutral cell culture media (pH 6.8–7.4).
How does NAD+ relate to mitochondrial research compounds like MOTS-c or SS-31?
While NAD+ acts as a primary redox coenzyme and sirtuin substrate, compounds like MOTS-c and SS-31 operate via distinct mitochondrial peptide pathways, making them complementary targets in cellular energy research.
Are PX1 Research compounds approved for animal or human clinical use?
No. All PX1 Research compounds, including NAD+ vials, are strictly manufactured and supplied for in vitro, laboratory, and preclinical research use only. They are not for human or veterinary administration.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.